For more information about Robinson Pharma's expanded manufacturing capabilities and to learn how the company can help your supplement manufacturing needs, please contact [email protected] or call 714 ...

According to industry estimates, the pharma industry’s spending on AI is expected to reach $3 billion by 2025. Pharma companies partnering with AI companies to develop platforms tailored to optimizing ...

Indian pharma has been focusing on innovation and process development to strengthen its capabilities in active pharmaceutical ingredients (APIs). This will see the industry reduce its dependence on ...

Thermo Fisher Scientific, one of the largest providers of services to the pharma industry, revealed mid-way through 2023 that it would look to cut $450 million in costs because of slowing demand.

Voicing their expectations for the upcoming Union Budget 2024–25, pharmaceutical industry experts urge the government to strengthen healthcare infrastructure and delivery capabilities ...

The Indian pharmaceutical industry is expected to grow at a compound annual rate (CAGR) of 12% and reach $130 billion by 2030, industry executives said at an industry event.

FOPE is set up with an objective to take up the common issues affecting the pharma industry at National level , ... "We are thrilled to join forces with FOPE to enhance the skills and capabilities of ...

COSTA MESA, Calif., April 29, 2025 /PRNewswire/ -- Robinson Pharma, a global leader in nutraceutical contract manufacturing, has announced a major expansion of its manufacturing capabilities. As ...